BeOne Medicines Statistics
Total Valuation
BeOne Medicines has a market cap or net worth of 30.35 billion. The enterprise value is 28.93 billion.
| Market Cap | 30.35B |
| Enterprise Value | 28.93B |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.29B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | -2.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 75.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 99.77 |
| PS Ratio | 7.26 |
| PB Ratio | 8.74 |
| P/TBV Ratio | 9.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 186.26 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -73.27 |
| EV / Sales | 6.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -135.64 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.95 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.16 |
| Interest Coverage | -18.93 |
Financial Efficiency
Return on equity (ROE) is -11.62% and return on invested capital (ROIC) is -3.86%.
| Return on Equity (ROE) | -11.62% |
| Return on Assets (ROA) | -3.06% |
| Return on Invested Capital (ROIC) | -3.86% |
| Return on Capital Employed (ROCE) | -7.30% |
| Revenue Per Employee | 380,067 |
| Profits Per Employee | -35,897 |
| Employee Count | 11,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.62% in the last 52 weeks. The beta is 0.30, so BeOne Medicines's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +11.62% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.61 |
| Average Volume (20 Days) | 499 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BeOne Medicines had revenue of 4.18 billion and -394.86 million in losses. Loss per share was -3.75.
| Revenue | 4.18B |
| Gross Profit | 3.55B |
| Operating Income | -278.99M |
| Pretax Income | -260.08M |
| Net Income | -394.86M |
| EBITDA | -104.31M |
| EBIT | -278.99M |
| Loss Per Share | -3.75 |
Balance Sheet
The company has 2.52 billion in cash and 1.10 billion in debt, giving a net cash position of 1.42 billion.
| Cash & Cash Equivalents | 2.52B |
| Total Debt | 1.10B |
| Net Cash | 1.42B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.47B |
| Book Value Per Share | 32.18 |
| Working Capital | 1.89B |
Cash Flow
In the last 12 months, operating cash flow was 162.93 million and capital expenditures -376.22 million, giving a free cash flow of -213.29 million.
| Operating Cash Flow | 162.93M |
| Capital Expenditures | -376.22M |
| Free Cash Flow | -213.29M |
| FCF Per Share | n/a |
Margins
Gross margin is 84.94%, with operating and profit margins of -6.67% and -9.44%.
| Gross Margin | 84.94% |
| Operating Margin | -6.67% |
| Pretax Margin | -6.22% |
| Profit Margin | -9.44% |
| EBITDA Margin | -2.50% |
| EBIT Margin | -6.67% |
| FCF Margin | n/a |
Dividends & Yields
BeOne Medicines does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.30% |
| FCF Yield | -0.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |